Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
No fee travel points cards often provide unique perks. Discover how these benefits can maximize your travel rewards.
19,690 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
A sweeping defense modernization plan totaling $185 billion could lift software-focused players like Palantir as miss...
Cardano’s ADA traded near the 26-cent mark as regulators named ADA a digital commodity, boosting optimism while price...
AppLovin exposes investors to a volatile mix of ad spend cycles and AI disruption fears. This guide breaks down the d...
The White House extended the deadline for Iran to reopen the Strait of Hormuz to April 6, sparking a fresh wave of oi...
Morgan Stanley cuts Li Auto to a $22 price target while maintaining an upbeat view on margin recovery tied to the L9 ...
Cathie Wood built a name on bold bets in disruptive tech. This piece breaks down how ARK Innovation rode dramatic swi...
In early 2026, women surpassed men in U.S. nonfarm payrolls, signaling a structural shift. This story explores the st...
AMD posted a blowout Q1 FY2026 with record revenue and booming data-center sales. The company guides stronger-than-ex...
Solana and Google Cloud have launched Pay.sh, a pay-as-you-go gateway that enables AI agents to purchase API access w...
Bitcoin surged to a three-month high, topping the $82,000 mark amid fresh geopolitical chatter and improving market s...
Magnum Ice Cream’s public split from Unilever has turned Ben & Jerry’s into a governance flashpoint. The brand’s acti...